Condition
Clostridium Butyricum Miyairi
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Unknown1
Recruiting1
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07422103Not ApplicableNot Yet Recruiting
PAN-CLO-BU (PANcreas-CLOstridium-BUtyricum)
NCT06548256Not ApplicableRecruitingPrimary
The Clinical Application of Clostridium Butyricum Miyairisan for Motor and Non-motor Symptoms in Parkinson's Disease
NCT03247101Not ApplicableUnknownPrimary
Probiotics for Gallstones in Post-bariatric Surgery Patients：A Prospective Randomized Trial
Showing all 3 trials